| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 155 |
| 1 | DEXAMETHASONE 1.5 MG | 155 |
| 2 | METHYLPREDNISOLONE | 77 |
| 3 | PREDNISOLONE | 54 |
| 4 | PREDNISOLONE ORAL | 54 |
| 5 | PREDNISOLONE ORAL SOLUTION | 54 |
| 6 | MEROPENEM | 52 |
| 7 | AMPHOTERICIN B | 49 |
| 8 | TACROLIMUS | 47 |
| 9 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 47 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | IVERMECTIN | 26 | 0.0057 |
| 1 | AMPHOTERICIN B | 49 | 0.0038 |
| 2 | MICAFUNGIN SODIUM | 21 | 0.0032 |
| 3 | TROPICAMIDE | 5 | 0.0031 |
| 4 | REMDESIVIR | 39 | 0.0029 |
| 5 | HYDROCORTISONE VALERATE | 1 | 0.0016 |
| 6 | MEROPENEM | 52 | 0.0016 |
| 7 | POSACONAZOLE | 23 | 0.0014 |
| 8 | BUSULFAN | 22 | 0.0014 |
| 9 | PURIXAN | 1 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 256 |
| 1 | Azole Antifungal [EPC] | 57 |
| 2 | Penem Antibacterial [EPC] | 52 |
| 3 | Lipid-based Polyene Antifungal [EPC] | 49 |
| 4 | Polyene Antifungal [EPC] | 49 |
| 5 | Glycopeptide Antibacterial [EPC] | 47 |
| 6 | Alkylating Drug [EPC] | 46 |
| 7 | Nucleoside Metabolic Inhibitor [EPC] | 44 |
| 8 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 39 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 36 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antiparasitic [EPC] | 26 | 0.0057 |
| 1 | Pediculicide [EPC] | 26 | 0.0055 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 49 | 0.0038 |
| 3 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 39 | 0.0029 |
| 4 | Echinocandin Antifungal [EPC] | 21 | 0.0026 |
| 5 | Penem Antibacterial [EPC] | 52 | 0.0015 |
| 6 | Polyene Antifungal [EPC] | 49 | 0.0012 |
| 7 | Asparagine-specific Enzyme [EPC] | 14 | 0.0010 |
| 8 | Glycopeptide Antibacterial [EPC] | 47 | 0.0007 |
| 9 | Interleukin-1 Receptor Antagonist [EPC] | 8 | 0.0005 |